Literature DB >> 3981013

Enzyme-linked immunosorbent assay for subclass distribution of human IgG and IgA antigen-specific antibodies.

M A Persson, L Hammarström, C I Smith.   

Abstract

In this study we describe an ELISA using monoclonal antibodies to IgG 1, 2, 3, 4, IgA1 and IgA2 for determining the subclass distribution of human-specific antibodies. No cross-reactivity of the subclass-specific reagents under the conditions used was observed. The sensitivity was 0.5 ng/ml for IgG1, 3, 4; 1.5 ng/ml for IgG2 and 50 ng/ml for IgA1 and IgA2. The reproducibility as described by the coefficient of variation calculated on repeated runs was 8-26% if the data were obtained by relating the absorbance values to a positive serum run in the assay, 17-58% when relating the OD figures to those of a standard myeloma plate. The method may be considered semiquantitative with high sensitivity and specificity, easy to handle and with small day-to-day variation. The assay has been applied to a number of antigens of protein and polysaccharide nature.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981013     DOI: 10.1016/0022-1759(85)90334-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  16 in total

1.  Early antibody responses in human schistosomiasis.

Authors:  B Evengård; L Hammarström; C I Smith; E Linder
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

2.  Long-term follow-up of anti-IgA antibodies in healthy IgA-deficient adults.

Authors:  S Koskinen; H Tölö; M Hirvonen; J Koistinen
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

3.  Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF.

Authors:  A Soininen; I Seppälä; T Wuorimaa; H Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

4.  Salivary IgG subclasses in individuals with and without homozygous IGHG gene deletions.

Authors:  P E Engström; G Norhagen; L Osipova; A Helal; V Wiebe; A Brusco; A O Carbonara; G Lefranc; M P Lefranc
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

5.  Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.

Authors:  A García-Merino; M A Persson; J Ernerudh; J J Díaz-Gil; T Olsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-09       Impact factor: 10.154

6.  IgG subclasses of specific antibodies in Ixodes ricinus-borne borreliosis.

Authors:  I Olsson; L Hammarström; C I Smith; A Hovmark; E Asbrink
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

7.  The antibody spectrum in individuals with defect expression of HLA class II and the LFA-1 glycoprotein family genes.

Authors:  C I Smith; C Bremard-Oury; F Le Deist; C Griscelli; P Aucouturier; G Möller; L Hammarström; J L Preud'homme; R S Weening
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.

Authors:  V Hammarström; K Pauksen; J Azinge; G Oberg; P Ljungman
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

9.  Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

Authors:  J J Ballet; G Sulcebe; L J Couderc; F Danon; C Rabian; M Lathrop; J P Clauvel; M Seligmann
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

10.  Development of anti-polysaccharide antibodies in asplenic children.

Authors:  L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.